ArticleJournal of pain research2026
Inhibition of the AMPK/PGC-1α/Mfn2 Axis is Associated with Mitochondria-ER Dysfunction and Ultrastructural Remodeling in a Rat Model of Myofascial Trigger Points.
Article in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Myofascial trigger points (MTrPs) represent the primary pathological basis of myofascial pain syndrome (MPS). However, the exact cellular and molecular mechanisms underlying MTrPs formation and maintenance remain largely unknown, especially regarding mitochondrial function, endoplasmic reticulum (ER) homeostasis, and energy metabolism regulation. Methods: A rat model of MTrPs was established by blunt striking combined with eccentric exercise. ATPase histochemistry, immunofluorescence staining, transmission electron microscopy (TEM), Western blotting, and quantitative real-time polymerase chain reaction (qRT-PCR) were used to investigate muscle fiber type conversion, ultrastructural changes, and the expression levels of key molecules involved in mitochondrial energy metabolism. Results: Muscle fibers in the MTrPs model exhibited a phenotypic switch from type I to type II fibers. Ultrastructurally, the MTrPs region showed abnormalities, including swollen and vacuolar mitochondria with matrix rarefaction, dilated ER cisternae, and significantly increased mitochondria-ER contacts (MERCs). The AMPK/PGC-1α/Mfn2 signaling axis and MEF2 were significantly downregulated at both mRNA and protein levels. Conclusion: Mitochondrial-ER dysfunction, energy metabolism disturbance, and muscle ultrastructural remodeling are associated with the pathophysiology of MTrPs, and these alterations may be linked to the downregulation of the AMPK/PGC-1α/Mfn2 pathway. These findings provide support for the "energy crisis" hypothesis of MTrPs from both molecular and ultrastructural perspectives, and identify potential therapeutic targets for MPS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.